Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry announcements.

Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry announcements.

The PhilRx-powered platform coordinates prescription fulfillment, benefits verification, prior authorizations, and eligible patient savings programs Harrow plans to expand the platform’s features and ...

An IND submission is planned for Q1 2027, followed by a phase 1/2 clinical trial pending regulatory clearance Link Biologics has completed its investigational new drug (IND)-enabling preclinical ...

The affiliation aims to preserve physician-led governance while expanding retina services, research opportunities, and access to clinical trials Prism Vision Group has acquired Spectrum Vision ...

Clinical trials involving more than 1,200 patients demonstrated 92%-93% sensitivity, 89%-94% specificity, and greater than 99% imageability The FDA-cleared technology enables autonomous diabetic ...

Existing initiatives have reached nearly 60 million children through Sight For Kids and helped restore sight to more than 70,000 cataract patients The company is supporting ophthalmic training, ...

OpZira's subsidiary AdaptDx completed its Stage II audit, advancing ISO certification efforts and plans for European CE marking in 2027 AdaptDx Pro measures rod-mediated dark adaptation, a functional ...

Benefits include 0% N3 headset financing, quarterly Neurolens rebates, and preferred pricing on Sequel lenses Program benefits begin December 1, 2026, with early access enrollment closing December 31, ...

Zeiss plans to expand its Aloka Vision model to at least two additional countries by 2028, including support for post-cataract care Two initiatives each aim to reach an additional 1 million people ...